Article Versions Notes

Yanagihara K, Yoshida M, Awaji K, Yamakawa T, Kato S, Tamura M, Nagata K. Real-World Outcomes of Subcutaneous PHESGO^® in HER2-Positive Breast Cancer: Pathological Response, Sequencing, and Safety. Current Oncology. 2025; 32(12):658. https://doi.org/10.3390/curroncol32120658

Yanagihara, Keiko, Masato Yoshida, Kensaku Awaji, Tamami Yamakawa, Sena Kato, Miki Tamura, and Koji Nagata. 2025. "Real-World Outcomes of Subcutaneous PHESGO^® in HER2-Positive Breast Cancer: Pathological Response, Sequencing, and Safety" Current Oncology 32, no. 12: 658. https://doi.org/10.3390/curroncol32120658

Yanagihara, K., Yoshida, M., Awaji, K., Yamakawa, T., Kato, S., Tamura, M., & Nagata, K. (2025). Real-World Outcomes of Subcutaneous PHESGO^® in HER2-Positive Breast Cancer: Pathological Response, Sequencing, and Safety. Current Oncology, 32(12), 658. https://doi.org/10.3390/curroncol32120658